Aris Global introduces solution suite for integrating data from EDC and clinical safety

Aris Global, a leading provider of software solutions for the life sciences industry, today introduced Total Clinical 2.0, an integrated solution suite designed to help life science organizations enter clinical safety data once and share seamlessly across their enterprise. Total Clinical is available on a hosted, managed platform and includes a full range of delivery and support services.

“Our approach is to focus on 'smart integration' across core systems and enable companies to enter data once and share seamlessly across departments.”

Now generally available, Total Clinical 2.0 integrates data from EDC and clinical safety to help companies improve data consistency and accuracy by eliminating redundancies in data entry, coding and SAE reconciliation. The Total Clinical 2.0 solution integrates four key clinical processes:

• Electronic data capture: agCapture™ is a feature-rich, proven EDC system that includes award-winning, integrated decision support functionality. It is based on software from Aris Global and InferMed and is fully scalable to support single site, multiple sites, and large, international trials.
• Clinical safety gateway: agXchange IRT™ enables companies to securely and efficiently receive, review and assess safety data from agCapture before import into the ARISg™ safety system. The solution validates the data for completeness and accuracy, and provides a complete audit trail of data received from the EDC system.
• Clinical adverse event reporting: ARISg™ is the market-leading pharmacovigilance and clinical safety system used by more than 300 companies worldwide. ARISg is also available on its hosted and managed platform, agOnDemand™.
• Safety report distribution: agXchange SIR™ automates safety report distribution to investigators, IRBs and ethics committees. The solution delivers a significant return on investment as it eliminates manual and labor-intensive effort required by clinical staff to print, sort and ship the increasing volume of safety information.

"Drug development costs can be significantly reduced by eliminating the overlap and redundant processes that exist across different departments," said Dr. Sylva Collins, Aris Global vice president of e-Clinical solutions. "Our approach is to focus on 'smart integration' across core systems and enable companies to enter data once and share seamlessly across departments."